» Articles » PMID: 21481279

Lysosomotropic Agents As HCV Entry Inhibitors

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2011 Apr 13
PMID 21481279
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

HCV has two envelop proteins named as E1 and E2 which play an important role in cell entry through two main pathways: direct fusion at the plasma membrane and receptor-mediated endocytosis. Fusion of the HCV envelope proteins is triggered by low pH within the endosome. Lysosomotropic agents (LA) such as Chloroquine and Ammonium chloride (NH₄Cl) are the weak bases and penetrate in lysosome as protonated form and increase the intracellular pH. To investigate the antiviral effect of LA (Chloroquine and NH₄Cl) on pH dependent endocytosis, HCV pseudoparticles (HCVpp) of 1a and 3a genotype were produced and used to infect liver cells. The toxicological effects of Chloroquine and NH₄Cl were tested in liver cells through MTT cell proliferation assay. For antiviral screening of Chloroquine and NH₄Cl, liver cells were infected with HCVpp of 3a and 1a genotype in the presence or absence of different concentrations of Chloroquine and NH₄Cl and there luciferase activity was determined by using a luminometer. The results demonstrated that Chloroquine and NH₄Cl showed more than 50% reduction of virus infectivity at 50 μM and 10 mM concentrations respectively. These results suggest that inhibition of HCV at fusion step by increasing the lysosomal pH will be better option to treat chronic HCV.

Citing Articles

Impact of Enniatin B and Beauvericin on Lysosomal Cathepsin B Secretion and Apoptosis Induction.

Aufy M, Abdelaziz R, Hussein A, Topcagic N, Shamroukh H, Abdel-Maksoud M Int J Mol Sci. 2023; 24(3).

PMID: 36768354 PMC: 9916760. DOI: 10.3390/ijms24032030.


Exogenous loading of extracellular vesicles, virus-like particles, and lentiviral vectors with supercharged proteins.

Breyne K, Ughetto S, Rufino-Ramos D, Mahjoum S, Grandell E, Almeida L Commun Biol. 2022; 5(1):485.

PMID: 35590035 PMC: 9120435. DOI: 10.1038/s42003-022-03440-7.


Hepatitis C Virus Alters Macrophage Cholesterol Metabolism Through Interaction with Scavenger Receptors.

Jennelle L, Magoro T, Angelucci A, Dandekar A, Hahn Y Viral Immunol. 2022; 35(3):223-235.

PMID: 35467430 PMC: 9063163. DOI: 10.1089/vim.2021.0101.


Identification and Development of Therapeutics for COVID-19.

Rando H, Wellhausen N, Ghosh S, Lee A, Dattoli A, Hu F mSystems. 2021; 6(6):e0023321.

PMID: 34726496 PMC: 8562484. DOI: 10.1128/mSystems.00233-21.


Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery.

Li X, Peng T Front Pharmacol. 2021; 12:660710.

PMID: 34017257 PMC: 8129523. DOI: 10.3389/fphar.2021.660710.


References
1.
Flint M, McKeating J . The role of the hepatitis C virus glycoproteins in infection. Rev Med Virol. 2000; 10(2):101-17. DOI: 10.1002/(sici)1099-1654(200003/04)10:2<101::aid-rmv268>3.0.co;2-w. View

2.
Savarino A, Gennero L, Chen H, Serrano D, Malavasi F, Boelaert J . Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS. 2001; 15(17):2221-9. DOI: 10.1097/00002030-200111230-00002. View

3.
Thorens B, Vassalli P . Chloroquine and ammonium chloride prevent terminal glycosylation of immunoglobulins in plasma cells without affecting secretion. Nature. 1986; 321(6070):618-20. DOI: 10.1038/321618a0. View

4.
Nousbaum J, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C . Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med. 1995; 122(3):161-8. DOI: 10.7326/0003-4819-122-3-199502010-00001. View

5.
Drummer H, Maerz A, Poumbourios P . Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett. 2003; 546(2-3):385-90. DOI: 10.1016/s0014-5793(03)00635-5. View